Search Thermo Fisher Scientific
Invitrogen™
dNTP Mix (2.5 mM)
Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP,Read more
PromotionPromo code:P5906365
Don't miss out: buy 3, only pay for 2
PromotionPromo code:RPUZZ25
Stock up on essentials to piece your discovery together
| Catalog Number | Quantity |
|---|---|
| R72501 | 1 mL |
Catalog number R72501
Price (USD)
230.65
Online Exclusive
255.00Save 24.35 (10%)
Each
In stock
Quantity:
1 mL
Price (USD)
230.65
Online Exclusive
255.00Save 24.35 (10%)
Each
Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP, each at a concentration of 2.5 mM. It is supplied in purified water and neutralized to pH 8.0 with NaOH. 2.5 mM dNTP Mix is suitable for use in a wide variety of molecular applications.
Applications
• Traditional PCR
• Sequencing
• cDNA synthesis
• Nick translation
• TdT-tailing reactions
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Concentration2.5 mM
Quantity1 mL
Shipping ConditionDry Ice
For Use With (Application)Standard PCR
FormLiquid
Label or DyeUnlabeled
Unit SizeEach
Contents & Storage
dNTP Mix, 2.5 mM (2 x 500 μL)
Store at –20°C.
Store at –20°C.
Have questions about this product? Ask our AI assisted search.
Generating response
This is an AI-powered search and may not always get things right. You can help us make it better with a thumbs up or down on individual answers or by selecting the “Give feedback" button. Your search history and customer login information may be retained by Thermo Fisher and processed in accordance with our
Privacy Notice.
Customers who viewed this item also viewed
Documents & Downloads
Certificates
Search by lot number or partial lot number
0 results displayed, search above for a specific certificate
Product Information
Citations & References (1)
Search citations by name, author, journal title or abstract text
Citations & References
Abstract
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.
Journal:Proc Natl Acad Sci U S A
PubMed ID:11526240
Therapy-related acute myeloid leukemias (t-AML) with translocations of the MLL gene are associated with the use of topoisomerase II inhibitors. We established the emergence of the malignant clone in a child who developed t-AML with a t(11;19) (q23;p13.3) during treatment for acute lymphoblastic leukemia (ALL). The MLL-ENL and the reciprocal
1 total citations